Two Pharma Plays (FBIO & BCTX)
I’ve been looking for some diamonds in the rough that should hopefully have a nice return on investment. I’ve settled on two plays, one is a lotto ticket and one seems like it should hopefully be a safe play.
So my case for FBIO… current market cap of 80 million, however expecting to receive over 100 million in proceeds from the sale of the PRV by Cyprium. On top of that they have several new FDA approvals. A rosacea drug that has expanding coverage among others. The market cap and the growth rate of the company do not make sense when they will have over 100 million in cash and a growing pipeline.
Now for the lotto ticket, BCTX. They have been working on a cancer vaccine for several years. Anyone who has invested in them previously probably has felt the pain of the drop. However, we are currently in a phase 3 trial for a CANCER VACCINE that has been ongoing for about a year with potential fast track approval from the government. It’s the most advanced treatment among others even when quoting pubmed. A little about this trial, the endpoint is overall survival in metastatic (stage 4) breast cancer compared to physicians treatment of choice. Considering overall survival takes some time to judge and that we have an earnings call coming up in mid June… if the news are positive we have endless room to run up. Currently valued with a market cap of 20 million.